Close
What would you like to look for?

14 August 2018

Azafaros (www.azafaros.com), a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round. BioGeneration Ventures is the founding investor.
Olivier Morand, Ph.D. and IMD alumnus, is joining Azafaros as Chief Executive Officer and member of the Board of Directors.
 
VISCHER advised on all Swiss legal issues related to the transaction. The VISCHER team includes Christian Wyss (Partner, Corporate/M&A), Marc Prinz (Partner, Employment) and Vera Keller (Junior Associate, Corporate/M&A).

Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases

Authors